文献速递气道管理

药物减少全麻气管插管后苏醒期咳嗽:系统综述与网状Meta分析

Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis.
PubMed 文献 · Br J Anaesth · 2020-02-22

该系统综述与网状Meta分析纳入70项RCT共5286例患者,比较利多卡因(静脉、套囊内、局部或气管内)、右美托咪定、瑞芬太尼和芬太尼减少全麻气管插管后中重度苏醒期咳嗽的效果。所有研究药物均优于安慰剂或无用药,右美托咪定SUCRA排名最高,但无单一药物显著优于其他药物。

要点

  • 所有研究药物减少中重度苏醒期咳嗽均优于安慰剂或无用药。
  • 右美托咪定SUCRA排名最高,其次为瑞芬太尼、芬太尼和利多卡因。
  • 套囊内利多卡因较安慰剂、右美托咪定、芬太尼和瑞芬太尼更易延长拔管时间。

核心结论

  • 所有研究药物减少中重度苏醒期咳嗽均优于安慰剂或无用药,右美托咪定排名最有效。

研究设计与样本

  • 系统综述与网状Meta分析,纳入70项RCT共5286例患者。
  • 检索八个医学文献数据库、会议摘要和文章参考文献,评估偏倚并提取数据。
  • 计算各治疗比较的合并比值比和95%CI,采用SUCRA确定相对排名。

主要发现

  • 所有研究药物减少中重度拔管期咳嗽的比值比均有利。
  • 无单一药物显著优于另一种药物。
  • 右美托咪定SUCRA排名最高,依次为瑞芬太尼、芬太尼、套囊内利多卡因、气管内/局部利多卡因和静脉利多卡因。
  • 仅减少重度咳嗽时瑞芬太尼排名最高。
  • 套囊内利多卡因较安慰剂、右美托咪定、芬太尼和瑞芬太尼更易延长拔管时间。

临床怎么用

  • 可选用右美托咪定、瑞芬太尼、芬太尼或利多卡因减少中重度苏醒期咳嗽。
  • 若需减少重度咳嗽可优先考虑瑞芬太尼。
  • 使用套囊内利多卡因时需注意拔管时间可能延长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emergence coughing can harm the patient following completion of surgery, but it is unclear which medication is most effective at reducing this event. We conducted a systematic review and network meta-analysis of RCTs to determine the medications' relative efficacies on decreasing moderate to severe emergence coughing after general anaesthesia. Medications studied were lidocaine (i.v., intracuff, topical, or tracheal application), dexmedetomidine, remifentanil, and fentanyl. METHODS: We searched eight different medical literature databases, conference abstracts, and article references. After screening, included citations were evaluated for bias and had their data extracted. Pooled odds ratios and 95% confidence intervals for each treatment comparison were calculated. A surface under the cumulative ranking curve analysis (SUCRA) determined the relative rank of each intervention to decrease moderate to severe emergence coughing. Subgroup analyses included severe coughing only, extubation times, type of maintenance anaesthetic, and dosages. RESULTS: The network meta-analysis included 70 studies and 5286 patients. All study medications had favourable odds in reducing moderate and severe peri-extubation coughing compared with either no medication or placebo. No single medication was favoured over another. Dexmedetomidine had the highest SUCRA rank, followed in order by remifentanil, fentanyl, and lidocaine via intracuff, tracheal/topical, and i.v. routes. Remifentanil was ranked highest for decreasing severe coughing only. Intracuff lidocaine had higher odds of prolonging extubation times compared with placebo, dexmedetomidine, fentanyl, and remifentanil. CONCLUSION: All study medications were better than placebo or no medication in reducing moderate to severe emergence cough, with dexmedetomidine ranked the most effective. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration number: CRD42018102870.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Tung A, Fergusson NA, Ng N, et al. Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis. Br J Anaesth. 2020. PMID: 32098647. doi:10.1016/j.bja.2019.12.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。